U.S. Tracheal Tube Introducers Market Size, Share & Trends Analysis Report By End Use (Hospitals And Clinics, Ambulatory Surgical Centers, Emergency Care Facilities/Urgent Care, Long-Term Facilities, Physician Offices) And Segment Forecasts, 2025 - 2030
This report can be delivered to the clients within 3 Business Days
U.S. Tracheal Tube Introducers Market Growth & Trends
The U.S. tracheal tube introducers market is anticipated treach USD 97.21 million by 2030, growing at a CAGR of 4.82% from 2025 t2030, according ta new report by Grand View Research, Inc. The market is driven by numerous factors such as surgical procedures and strategic activities by the players in the country. The increasing hospital admissions for surgeries and emergency conditions emerges as a significant opportunity in the U.S. tracheal tube introducers market. For instance, as per the article published in the journal “Critical Care Medicine” in September 2024, there were 18,313,637 ICU hospitalizations in Medicare in the U.S. This high number of hospitalizations increases the need for efficient airway management in hospitals and clinics.
Furthermore, a significant number of the young population is attracted tsmoking and tobacchabits, which correspondingly impacts the number of respiratory diseases. According tthe data published by the CDC in September 2024, around 49.2 million adults living in the U.S. reported tobaccuse. Moreover, according tthe data published by the American Lung Association in January 2024, around 11.6% of U.S. adults smoked cigarettes in 2022. Thus, an increasing number of individuals are anticipated tsuffer from respiratory and chronic illnesses due tthe presence of a large population having smoking habits. This increasing prevalence of respiratory illnesses is anticipated tboost the demand for early airway interventions in case of emergencies and thus propel the market growth.
Moreover, studies ongoing in the industry provide reliable information and are anticipated tincrease the adoption of tracheal tube introducers. For instance, according tan article published by the Association of Anesthetics in July 2024, a study was performed tunderstand tracheal tube introducer-associated airway trauma. The study concluded that the tracheal tube introducers are safe and reduce the risk of airway trauma. Furthermore, the study published by the Annals of Emergency Medicine in February 2024 found that the bougie (an endotracheal tube introducer), as an asset in the first intubation attempt, was associated with improved success in emergency department intubations. This study suggests that bougie should probably be used first and not as a rescue device. Thus, such studies are anticipated tsupport U.S. tracheal tube introducers market growth in the coming years.
U.S. Tracheal Tube Introducers Market Report Highlights
U.S. Tracheal Tube Introducers Market Growth & Trends
The U.S. tracheal tube introducers market is anticipated treach USD 97.21 million by 2030, growing at a CAGR of 4.82% from 2025 t2030, according ta new report by Grand View Research, Inc. The market is driven by numerous factors such as surgical procedures and strategic activities by the players in the country. The increasing hospital admissions for surgeries and emergency conditions emerges as a significant opportunity in the U.S. tracheal tube introducers market. For instance, as per the article published in the journal “Critical Care Medicine” in September 2024, there were 18,313,637 ICU hospitalizations in Medicare in the U.S. This high number of hospitalizations increases the need for efficient airway management in hospitals and clinics.
Furthermore, a significant number of the young population is attracted tsmoking and tobacchabits, which correspondingly impacts the number of respiratory diseases. According tthe data published by the CDC in September 2024, around 49.2 million adults living in the U.S. reported tobaccuse. Moreover, according tthe data published by the American Lung Association in January 2024, around 11.6% of U.S. adults smoked cigarettes in 2022. Thus, an increasing number of individuals are anticipated tsuffer from respiratory and chronic illnesses due tthe presence of a large population having smoking habits. This increasing prevalence of respiratory illnesses is anticipated tboost the demand for early airway interventions in case of emergencies and thus propel the market growth.
Moreover, studies ongoing in the industry provide reliable information and are anticipated tincrease the adoption of tracheal tube introducers. For instance, according tan article published by the Association of Anesthetics in July 2024, a study was performed tunderstand tracheal tube introducer-associated airway trauma. The study concluded that the tracheal tube introducers are safe and reduce the risk of airway trauma. Furthermore, the study published by the Annals of Emergency Medicine in February 2024 found that the bougie (an endotracheal tube introducer), as an asset in the first intubation attempt, was associated with improved success in emergency department intubations. This study suggests that bougie should probably be used first and not as a rescue device. Thus, such studies are anticipated tsupport U.S. tracheal tube introducers market growth in the coming years.
U.S. Tracheal Tube Introducers Market Report Highlights
- Based on end use, the EMS (Fire/Rescue/Ambulance/Hospital Based EMS) segment dominated the market and accounted for a revenue share of 39.21% in 2024. On the other hand, the hospitals and clinics segment is expected tregister the fastest CAGR during the forecast period owing tthe increasing demand and advanced healthcare infrastructure
- Intersurgical, Flexicare (Group) Limited, MEDLINE, Vygon SAS, and Dynarex Corporation are the key players in the U.S. tracheal tube introducers market.
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation and Scope
1.2. Segment Definitions
1.2.1. End Use
1.2.2. Country Scope
1.2.3. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.3. Country outlook
2.4. Competitive Insights
CHAPTER 3. TRACHEAL TUBE INTRODUCERS VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing Surgical Procedures
3.2.1.2. Rising Prevalence of Respiratory Diseases
3.2.1.3. Growing Aging Population
3.2.2. Market Restraint Analysis
3.2.2.1. Risk of Complications
3.3. Tracheal Tube Introducers Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic landscape
3.3.2.3. Social landscape
3.3.2.4. Technological landscape
3.3.2.5. Environmental landscape
3.3.2.6. Legal landscape
CHAPTER 4. U.S. TRACHEAL TUBE INTRODUCERS MARKET: SEGMENT ANALYSIS, BY END USE, 2018 - 2030 (USD MILLION AND VOLUME UNIT)
4.1. Definition and Scope
4.2. End Use Market Share Analysis, 2024 & 2030
4.3. U.S. Tracheal Tube Introducers Market, by End Use, 2018 to 2030
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030
4.4.1. Hospitals and Clinics
4.4.1.1. Hospitals and Clinics Market Estimates and Forecasts, 2018 to 2030 (USD Million)
4.4.2. Ambulatory Surgical Centers
4.4.2.1. Ambulatory Surgical Centers Market Estimates and Forecasts, 2018 to 2030 (USD Million)
4.4.3. Emergency Care Facilities/Urgent Care
4.4.3.1. Emergency Care Facilities/Urgent Care Market Estimates and Forecasts, 2018 to 2030 (USD Million)
4.4.4. Others (Long-Term Facilities, Physician Offices, Nursing Homes)
4.4.4.1. Others Market Estimates and Forecasts, 2018 to 2030 (USD Million)
4.4.5. EMS (Fire/Rescue/Ambulance/Hospital Based EMS)
4.4.5.1. EMS Market Estimates and Forecasts, 2018 to 2030 (USD Million)
CHAPTER 5. COMPETITIVE LANDSCAPE
5.1. Market Participant Categorization
5.2. Recent Developments & Impact Analysis by Key Market Participants
5.3. Company Market Share Analysis, 2024
5.4. Key Company Profiles
5.4.1. Intersurgical
5.4.1.1. Company overview
5.4.1.2. Financial performance
5.4.1.3. Product benchmarking
5.4.1.4. Strategic initiatives
5.4.2. Flexicare (Group) Limited
5.4.2.1. Company overview
5.4.2.2. Financial performance
5.4.2.3. Product benchmarking
5.4.2.4. Strategic initiatives
5.4.3. MEDLINE
5.4.3.1. Company overview
5.4.3.2. Financial performance
5.4.3.3. Product benchmarking
5.4.3.4. Strategic initiatives
5.4.4. Vygon SAS.
5.4.4.1. Company overview
5.4.4.2. Financial performance
5.4.4.3. Product benchmarking
5.4.4.4. Strategic initiatives
5.4.5. Dynarex Corporation
5.4.5.1. Company overview
5.4.5.2. Financial performance
5.4.5.3. Product benchmarking
5.4.5.4. Strategic initiatives
1.1. Market Segmentation and Scope
1.2. Segment Definitions
1.2.1. End Use
1.2.2. Country Scope
1.2.3. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.3. Country outlook
2.4. Competitive Insights
CHAPTER 3. TRACHEAL TUBE INTRODUCERS VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing Surgical Procedures
3.2.1.2. Rising Prevalence of Respiratory Diseases
3.2.1.3. Growing Aging Population
3.2.2. Market Restraint Analysis
3.2.2.1. Risk of Complications
3.3. Tracheal Tube Introducers Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic landscape
3.3.2.3. Social landscape
3.3.2.4. Technological landscape
3.3.2.5. Environmental landscape
3.3.2.6. Legal landscape
CHAPTER 4. U.S. TRACHEAL TUBE INTRODUCERS MARKET: SEGMENT ANALYSIS, BY END USE, 2018 - 2030 (USD MILLION AND VOLUME UNIT)
4.1. Definition and Scope
4.2. End Use Market Share Analysis, 2024 & 2030
4.3. U.S. Tracheal Tube Introducers Market, by End Use, 2018 to 2030
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030
4.4.1. Hospitals and Clinics
4.4.1.1. Hospitals and Clinics Market Estimates and Forecasts, 2018 to 2030 (USD Million)
4.4.2. Ambulatory Surgical Centers
4.4.2.1. Ambulatory Surgical Centers Market Estimates and Forecasts, 2018 to 2030 (USD Million)
4.4.3. Emergency Care Facilities/Urgent Care
4.4.3.1. Emergency Care Facilities/Urgent Care Market Estimates and Forecasts, 2018 to 2030 (USD Million)
4.4.4. Others (Long-Term Facilities, Physician Offices, Nursing Homes)
4.4.4.1. Others Market Estimates and Forecasts, 2018 to 2030 (USD Million)
4.4.5. EMS (Fire/Rescue/Ambulance/Hospital Based EMS)
4.4.5.1. EMS Market Estimates and Forecasts, 2018 to 2030 (USD Million)
CHAPTER 5. COMPETITIVE LANDSCAPE
5.1. Market Participant Categorization
5.2. Recent Developments & Impact Analysis by Key Market Participants
5.3. Company Market Share Analysis, 2024
5.4. Key Company Profiles
5.4.1. Intersurgical
5.4.1.1. Company overview
5.4.1.2. Financial performance
5.4.1.3. Product benchmarking
5.4.1.4. Strategic initiatives
5.4.2. Flexicare (Group) Limited
5.4.2.1. Company overview
5.4.2.2. Financial performance
5.4.2.3. Product benchmarking
5.4.2.4. Strategic initiatives
5.4.3. MEDLINE
5.4.3.1. Company overview
5.4.3.2. Financial performance
5.4.3.3. Product benchmarking
5.4.3.4. Strategic initiatives
5.4.4. Vygon SAS.
5.4.4.1. Company overview
5.4.4.2. Financial performance
5.4.4.3. Product benchmarking
5.4.4.4. Strategic initiatives
5.4.5. Dynarex Corporation
5.4.5.1. Company overview
5.4.5.2. Financial performance
5.4.5.3. Product benchmarking
5.4.5.4. Strategic initiatives
